Tuesday, June 23, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 602 of 1,261

  1. US 9789184

    Anti-EGFR antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  2. US 9790573

    Method for purification of 225AC from irradiated 226RA-targets

    Actinium Phamaceuticals, Inc. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  3. US 9789224

    Compositions and methods for cardiac therapy

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  4. US 9789180

    D-amino acid derivative-modified peptidoglycan and methods of use thereof

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  5. US 9789185

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  6. US 9789176

    Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus

    Regents of the University of Minnesota · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  7. US 9789134

    Agent for the selective adjustment of blood lipids

    FEDERAL STATE BUDGETARY SCIENTIFIC INSTITUTION “RESEARCH INSTITUTE FOR CARDIOLOGY” · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  8. US 9789136

    Multipotent adult stem cells and methods for isolation

    Regents of the University of Minnesota · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  9. US 9789144

    Inhibition of hypoxia-inducible factor activity with Carica papaya extracts

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  10. US 9789131

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  11. US 9789116

    Compositions and methods of modulating short-chain dehydrogenase activity

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  12. US 9789057

    Pharmaceutical delivery system

    Perrigo Pharma International Designated Activity Company · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  13. US 9789095

    Inhibitors of calcium-activated chloride channels

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  14. US 9789084

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  15. US 9789083

    Nitrogen-containing heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  16. US 9789031

    Dental adhesive kit

    KURARAY NORITAKE DENTAL INC. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  17. US 9790499

    Functionally-modified oligonucleotides and subunits thereof

    Sarepta Therapeutics, Inc. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  18. US 9790495

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  19. US 9790285

    Anti-CD38 antibodies

    Takeda Pharmaceutical Company Limited · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  20. US 9790281

    Humanized anti-CD134 (OX40) antibodies and uses thereof

    Biocerox Products B.V. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  21. US 9790506

    Diagnostic and screening methods for atopic dermatitis

    The Regents of the University of California · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  22. US 9790473

    Human Ebola virus species and compositions and methods thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  23. US 9790261

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  24. US 9790220

    Substituted cyclopentanes, tetrahydrofuranes and pyrrolidines as orexin receptor antagonists

    Takeda Pharmaceutical Company Limited · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.